Recent News

• 08.11.2025 - 2025 Half-Year Business and Financial Report (as of June 30, 2025)
• 08.11.2025 - 2025 Half-Year Business and Financial Report (as of June 30, 2025)
• 06.06.2025 - 2025 Annual General Meeting (AGM)
• 06.06.2025 - 2025 Annual General Meeting (AGM)
• 06.02.2025 - 2025 Q1 Financial Results (as of March 31, 2025)
• 06.02.2025 - 2025 Q1 Financial Results (as of March 31, 2025)
• 04.22.2025 - Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
• 04.22.2025 - Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
• 04.22.2025 - Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
• 04.22.2025 - Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

Recent Filings

• 04.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.24.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.24.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.24.2025 - EX-99.1 EX-99.1